Birmingham, AL, United States of America

Bryan Walter Tillman


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2001-2005

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Immunomodulation by Bryan Walter Tillman

Introduction

Bryan Walter Tillman is an accomplished inventor based in Birmingham, Alabama. He has made significant contributions to the field of immunology through his innovative patents. With a total of two patents to his name, Tillman is recognized for his work in enhancing gene delivery systems for immune cells.

Latest Patents

Tillman's latest patents focus on immunomodulation through genetic modification of dendritic cells and B cells. The first patent provides a CD40-targeted gene delivery system and a CD40-targeted recombinant adenoviral vector for the genetic manipulation of these immune cells. This invention enhances dendritic cell-based immunotherapy by improving gene delivery to immune system cells. The second patent describes a gene delivery vector that generates genetically modified dendritic cells and B cells, which are crucial for modulating immunity. This technology addresses the previous challenges of gene transfer resistance in these cell types, leading to significant advancements in immunotherapy.

Career Highlights

Bryan Walter Tillman is associated with the UAB Research Foundation, where he continues to develop innovative solutions in the field of immunology. His work has the potential to transform therapeutic approaches to various diseases by enhancing the immune response.

Collaborations

Tillman collaborates with notable professionals in his field, including David T. Curiel, who shares a commitment to advancing immunological research and technology.

Conclusion

Bryan Walter Tillman's contributions to immunomodulation through genetic modification represent a significant advancement in the field of immunology. His innovative patents pave the way for new therapeutic strategies that could enhance immune responses and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…